{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:48:06Z","timestamp":1767991686585,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"DOI":"10.7759\/cureus.95851","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:50:29Z","timestamp":1761958229000},"source":"Crossref","is-referenced-by-count":1,"title":["Dexmedetomidine for Alcohol Withdrawal: Looks Can Be Deceiving"],"prefix":"10.7759","author":[{"given":"Morgan","family":"Riggan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert  S","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Biary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Biary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III","volume":"72","author":"Grant BF","year":"2015","unstructured":"Grant BF, Goldstein RB, Saha TD, et al.. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry. 2015, 72:757-66. 10.1001\/jamapsychiatry.2015.0584","journal-title":"JAMA Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.10574","article-title":"Will this hospitalized patient develop severe alcohol withdrawal syndrome? The rational clinical examination systematic review","volume":"320","author":"Wood E","year":"2018","unstructured":"Wood E, Albarqouni L, Tkachuk S, et al.. Will this hospitalized patient develop severe alcohol withdrawal syndrome? The rational clinical examination systematic review. JAMA. 2018, 320:825-33. 10.1001\/jama.2018.10574","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15288\/qjsa.1955.16.001","article-title":"Experimental study on etiology of rum fits","volume":"16","author":"Isabell H","year":"1955","unstructured":"Isabell H, Fraser HF, Wikler A, Belleville RE, Eisenman AJ. Experimental study on etiology of rum fits. Q J Stud Alcohol. 1955, 16:1-33. 10.15288\/qjsa.1955.16.001","journal-title":"Q J Stud Alcohol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.3.332","article-title":"The glutamatergic basis of human alcoholism","volume":"152","author":"Tsai G","year":"1995","unstructured":"Tsai G, Gastfriend DR, Coyle JT. The glutamatergic basis of human alcoholism. Am J Psychiatry. 1995, 152:332-40. 10.1176\/ajp.152.3.332","journal-title":"Am J Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0733-8627(05)70124-3","article-title":"Withdrawal syndromes","volume":"18","author":"Olmedo R","year":"2000","unstructured":"Olmedo R, Hoffman RS. Withdrawal syndromes. Emerg Med Clin North Am. 2000, 18:273-88. 10.1016\/s0733-8627(05)70124-3","journal-title":"Emerg Med Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM193906082202302","article-title":"Delirium tremens: a study of cases at the Boston City Hospital, 1915-1936","volume":"220","author":"Moore M","year":"1939","unstructured":"Moore M, Gray MG. Delirium tremens: a study of cases at the Boston City Hospital, 1915-1936. New Eng J Med. 1939, 220:953-6. 10.1056\/NEJM193906082202302","journal-title":"New Eng J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2005.03932.x","article-title":"Clinical predictors for delirium tremens in alcohol dependence","volume":"20","author":"Lee JH","year":"2005","unstructured":"Lee JH, Jang MK, Lee JY, et al.. Clinical predictors for delirium tremens in alcohol dependence. J Gastroenterol Hepatol. 2005, 20:1833-7. 10.1111\/j.1440-1746.2005.03932.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-12-39","article-title":"Risk factors for lethal outcome in patients with delirium tremens - psychiatrist's perspective: a nested case-control study","volume":"12","author":"Ignjatovic-Ristic D","year":"2013","unstructured":"Ignjatovic-Ristic D, Rancic N, Novokmet S, Jankovic S, Stefanovic S. Risk factors for lethal outcome in patients with delirium tremens - psychiatrist's perspective: a nested case-control study. Ann Gen Psychiatry. 2013, 12:39. 10.1186\/1744-859X-12-39","journal-title":"Ann Gen Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agp087","article-title":"Analysis of the factors determining survival of alcoholic withdrawal syndrome patients in a general hospital","volume":"45","author":"Monte R","year":"2010","unstructured":"Monte R, Rabu\u00f1al R, Casariego E, L\u00f3pez-Agreda H, Mateos A, P\u00e9rtega S. Analysis of the factors determining survival of alcoholic withdrawal syndrome patients in a general hospital. Alcohol Alcohol. 2010, 45:151-8. 10.1093\/alcalc\/agp087","journal-title":"Alcohol Alcohol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000256841.28351.80","article-title":"A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens","volume":"35","author":"Gold JA","year":"2007","unstructured":"Gold JA, Rimal B, Nolan A, Nelson LS. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med. 2007, 35:724-30. 10.1097\/01.CCM.0000256841.28351.80","journal-title":"Crit Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.02.002","article-title":"The emergency medicine management of severe alcohol withdrawal","volume":"35","author":"Long D","year":"2017","unstructured":"Long D, Long B, Koyfman A. The emergency medicine management of severe alcohol withdrawal. Am J Emerg Med. 2017, 35:1005-11. 10.1016\/j.ajem.2017.02.002","journal-title":"Am J Emerg Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.125.12.1640","article-title":"Treatment of the acute alcohol withdrawal state: a comparison of four drugs","volume":"125","author":"Kaim SC","year":"1969","unstructured":"Kaim SC, Klett CJ, Rothfeld B. Treatment of the acute alcohol withdrawal state: a comparison of four drugs. Am J Psychiatry. 1969, 125:1640-6. 10.1176\/ajp.125.12.1640","journal-title":"Am J Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2012.07.056","article-title":"Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study","volume":"44","author":"Rosenson J","year":"2013","unstructured":"Rosenson J, Clements C, Simon B, et al.. Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study. J Emerg Med. 2013, 44:592-598.e2. 10.1016\/j.jemermed.2012.07.056","journal-title":"J Emerg Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.1821629","article-title":"Analysis of safety and efficacy of dexmedetomidine as adjunctive therapy for alcohol withdrawal in ICU","volume":"145","author":"Kachalia A","year":"2014","unstructured":"Kachalia A, Kachalia K, Nagalli S, Rahman H, Lopez R, Rizzo V. Analysis of safety and efficacy of dexmedetomidine as adjunctive therapy for alcohol withdrawal in ICU. Chest. 2014, 145:207A. 10.1378\/chest.1821629","journal-title":"Chest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.1991617","article-title":"A retrospective analysis of dexmedetomidine use for alcohol withdrawal syndrome in critical care patients","volume":"146","author":"Au T","year":"2014","unstructured":"Au T, Malesker M, Hilleman D, Walters R, Wichman C, Morrow L. A retrospective analysis of dexmedetomidine use for alcohol withdrawal syndrome in critical care patients. Chest. 2014, 146:225A. 10.1378\/chest.1991617","journal-title":"Chest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000141","article-title":"A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal","volume":"42","author":"Mueller SW","year":"2014","unstructured":"Mueller SW, Preslaski CR, Kiser TH, Fish DN, Lavelle JC, Malkoski SP, MacLaren R. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal. Crit Care Med. 2014, 42:1131-9. 10.1097\/CCM.0000000000000141","journal-title":"Crit Care Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/2110-5820-2-12","article-title":"Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU","volume":"2","author":"Rayner SG","year":"2012","unstructured":"Rayner SG, Weinert CR, Peng H, Jepsen S, Broccard AF. Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Intensive Care. 2012, 2:12. 10.1186\/2110-5820-2-12","journal-title":"Ann Intensive Care"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1994.03520070039035","article-title":"Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial","volume":"272","author":"Saitz R","year":"1994","unstructured":"Saitz R, Mayo-Smith MF, Roberts MS, Redmond HA, Bernard DR, Calkins DR. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA. 1994, 272:519-23.","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4065\/76.7.695","article-title":"Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients","volume":"76","author":"Jaeger TM","year":"2001","unstructured":"Jaeger TM, Lohr RH, Pankratz VS. Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients. Mayo Clin Proc. 2001, 76:695-701. 10.4065\/76.7.695","journal-title":"Mayo Clin Proc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.10.1117","article-title":"Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial","volume":"162","author":"Daeppen JB","year":"2002","unstructured":"Daeppen JB, Gache P, Landry U, Sekera E, Schweizer V, Gloor S, Yersin B. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med. 2002, 162:1117-21. 10.1001\/archinte.162.10.1117","journal-title":"Arch Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1017\/cem.2019.421","article-title":"Benzodiazepine resistant alcohol withdrawal: what is the clinician's preferred definition?","volume":"22","author":"Langlois H","year":"2020","unstructured":"Langlois H, Cormier M, Villeneuve E, Hoffman RS, Longo C, Gosselin S. Benzodiazepine resistant alcohol withdrawal: what is the clinician's preferred definition?. CJEM. 2020, 22:165-9. 10.1017\/cem.2019.421","journal-title":"CJEM"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1989.tb00290.x","article-title":"Is clonidine useful in the treatment of alcohol withdrawal?","volume":"13","author":"Robinson BJ","year":"1989","unstructured":"Robinson BJ, Robinson GM, Maling TJ, Johnson RH. Is clonidine useful in the treatment of alcohol withdrawal?. Alcohol Clin Exp Res. 1989, 13:95-8. 10.1111\/j.1530-0277.1989.tb00290.x","journal-title":"Alcohol Clin Exp Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90744-3","article-title":"Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist","volume":"150","author":"Virtanen R","year":"1988","unstructured":"Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol. 1988, 150:9-14. 10.1016\/0014-2999(88)90744-3","journal-title":"Eur J Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000001133","article-title":"Dexmedetomidine exerts a negative chronotropic action on sinoatrial node cells through the activation of imidazoline receptors","volume":"78","author":"Ishihara M","year":"2021","unstructured":"Ishihara M, Kojima A, Ding WG, Kitagawa H, Matsuura H. Dexmedetomidine exerts a negative chronotropic action on sinoatrial node cells through the activation of imidazoline receptors. J Cardiovasc Pharmacol. 2021, 78:826-38. 10.1097\/FJC.0000000000001133","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2001.11927725","article-title":"Dexmedetomidine: a novel sedative-analgesic agent","volume":"14","author":"Gertler R","year":"2001","unstructured":"Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent). 2001, 14:13-21. 10.1080\/08998280.2001.11927725","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2044.1999.00659.x","article-title":"alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role","volume":"54","author":"Khan ZP","year":"1999","unstructured":"Khan ZP, Ferguson CN, Jones RM. alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia. 1999, 54:146-65. 10.1046\/j.1365-2044.1999.00659.x","journal-title":"Anaesthesia"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-012-1381-y","article-title":"Use of dexmedetomidine for the treatment of alcohol withdrawal syndrome in critically ill patients: a retrospective case series","volume":"26","author":"DeMuro JP","year":"2012","unstructured":"DeMuro JP, Botros DG, Wirkowski E, Hanna AF. Use of dexmedetomidine for the treatment of alcohol withdrawal syndrome in critically ill patients: a retrospective case series. J Anesth. 2012, 26:601-5. 10.1007\/s00540-012-1381-y","journal-title":"J Anesth"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-015-0075-7","article-title":"Addition of dexmedetomidine to benzodiazepines for patients with alcohol withdrawal syndrome in the intensive care unit: a randomized controlled study","volume":"5","author":"Bielka K","year":"2015","unstructured":"Bielka K, Kuchyn I, Glumcher F. Addition of dexmedetomidine to benzodiazepines for patients with alcohol withdrawal syndrome in the intensive care unit: a randomized controlled study. Ann Intensive Care. 2015, 5:33. 10.1186\/s13613-015-0075-7","journal-title":"Ann Intensive Care"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1448","article-title":"Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines","volume":"34","author":"Crispo AL","year":"2014","unstructured":"Crispo AL, Daley MJ, Pepin JL, Harford PH, Brown CV. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines. Pharmacotherapy. 2014, 34:910-7. 10.1002\/phar.1448","journal-title":"Pharmacotherapy"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/0885066614554908","article-title":"Evaluation of early dexmedetomidine addition to the standard of care for severe alcohol withdrawal in the ICU: a retrospective controlled cohort study","volume":"31","author":"VanderWeide LA","year":"2016","unstructured":"VanderWeide LA, Foster CJ, MacLaren R, Kiser TH, Fish DN, Mueller SW. Evaluation of early dexmedetomidine addition to the standard of care for severe alcohol withdrawal in the ICU: a retrospective controlled cohort study. J Intensive Care Med. 2016, 31:198-204. 10.1177\/0885066614554908","journal-title":"J Intensive Care Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/08850666231152837","article-title":"Evaluation of dexmedetomidine as an adjunct to phenobarbital for alcohol withdrawal in critically ill patients","volume":"38","author":"Ware LR","year":"2023","unstructured":"Ware LR, Schuler BR, Goodberlet MZ, Marino KK, Lupi KE, DeGrado JR. Evaluation of dexmedetomidine as an adjunct to phenobarbital for alcohol withdrawal in critically ill patients. J Intensive Care Med. 2023, 38:553-61. 10.1177\/08850666231152837","journal-title":"J Intensive Care Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ph17091125","article-title":"Dexmedetomidine as adjunctive therapy for the treatment of alcohol withdrawal syndrome: a systematic review and meta-analysis","volume":"17","author":"Fiore M","year":"2024","unstructured":"Fiore M, Alfieri A, Torretta G, et al.. Dexmedetomidine as adjunctive therapy for the treatment of alcohol withdrawal syndrome: a systematic review and meta-analysis. Pharmaceuticals (Basel). 2024, 17:1125. 10.3390\/ph17091125","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1539","article-title":"Use of propofol plus dexmedetomidine in patients experiencing severe alcohol withdrawal in the intensive care unit","volume":"60","author":"Love K","year":"2020","unstructured":"Love K, Zimmermann AE. Use of propofol plus dexmedetomidine in patients experiencing severe alcohol withdrawal in the intensive care unit. J Clin Pharmacol. 2020, 60:439-43. 10.1002\/jcph.1539","journal-title":"J Clin Pharmacol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14911","article-title":"Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE-4): alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department","volume":"31","author":"Borgundvaag B","year":"2024","unstructured":"Borgundvaag B, Bellolio F, Miles I, et al.. Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE-4): alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department. Acad Emerg Med. 2024, 31:425-55. 10.1111\/acem.14911","journal-title":"Acad Emerg Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/0897190020977755","article-title":"Effect of adjunctive dexmedetomidine in the treatment of alcohol withdrawal compared to benzodiazepine symptom-triggered therapy in critically ill patients: the EvADE study","volume":"35","author":"Collier TE","year":"2022","unstructured":"Collier TE, Farrell LB, Killian AD, Kataria VK. Effect of adjunctive dexmedetomidine in the treatment of alcohol withdrawal compared to benzodiazepine symptom-triggered therapy in critically ill patients: the EvADE study. J Pharm Pract. 2022, 35:356-62. 10.1177\/0897190020977755","journal-title":"J Pharm Pract"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2016.04.010","article-title":"Restraint related deaths and excited delirium syndrome in Ontario (2004-2011)","volume":"41","author":"Michaud A","year":"2016","unstructured":"Michaud A. Restraint related deaths and excited delirium syndrome in Ontario (2004-2011). J Forensic Leg Med. 2016, 41:30-5. 10.1016\/j.jflm.2016.04.010","journal-title":"J Forensic Leg Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/01612840.2021.1978597","article-title":"Patient experience of physical restraint in the acute setting: a systematic review of the qualitative research evidence","volume":"43","author":"Douglas L","year":"2022","unstructured":"Douglas L, Donohue G, Morrissey J. Patient experience of physical restraint in the acute setting: a systematic review of the qualitative research evidence. Issues Ment Health Nurs. 2022, 43:473-81. 10.1080\/01612840.2021.1978597","journal-title":"Issues Ment Health Nurs"},{"key":"ref38","article-title":"Kindling in alcohol withdrawal","volume":"22","author":"Becker HC","year":"1998","unstructured":"Becker HC. Kindling in alcohol withdrawal. Alcohol Health Res World. 1998, 22:25-33.","journal-title":"Alcohol Health Res World"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/335569-dexmedetomidine-for-alcohol-withdrawal-looks-can-be-deceiving","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:50:31Z","timestamp":1761958231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/335569-dexmedetomidine-for-alcohol-withdrawal-looks-can-be-deceiving"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.95851","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,31]]}}}